起草一个蓝图,设计成功的临床试验在克隆性血液形成

Shyam A Patel1, Lachelle D Weeks2

  • 1Department of Medicine-Division of Hematology/Oncology, Center for Clinical and Translational Science, UMass Chan Medical School, Worcester, Massachusetts, USA.

PubMed
概括

设计克隆性血液形成的临床试验需要个性化的遗传风险评估,以防止骨髓瘤瘤的进展. 战略终点选择和均衡的干预措施对于有效的治疗开发至关重要.